Variables | Â | P | HR | 95.0% CI | |
---|---|---|---|---|---|
Lower | Upper | ||||
Drug | Sorafenib vs Sunitinib | <0.001 | 1.420 | 1.211 | 1.664 |
Gender | Male vs Female | 0.414 | 1.074 | 0.906 | 1.273 |
Age | <65 vs > =65 | 0.194 | 0.879 | 0.723 | 1.068 |
Pathology | Clear cell vs Non clear cell | 0.024 | 1.312 | 1.037 | 1.660 |
ECOG | 0 vs 1 vs 2 vs 3 | <0.001 | 1.245 | 1.105 | 1.402 |
Previous nephrectomy | No vs Yes | 0.500 | 0.931 | 0.755 | 1.147 |
MSKCC | Low vs median vs High | 0.043 | 1.253 | 1.007 | 1.558 |
HENG | Low vs median vs High | <0.001 | 1.458 | 1.198 | 1.774 |
Number of metastatic organs | 1 vs 2 vs 3 vs 4 | 0.679 | 1.033 | 0.886 | 1.204 |
Lung metastasis | Yes vs No | 0.175 | 1.173 | 0.931 | 1.478 |
Single lung metastasis | No vs Yes | 0.188 | 0.834 | 0.637 | 1.092 |
Bone metastasis | Yes vs No | 0.108 | 1.193 | 0.962 | 1.481 |
Single bone metastasis | No vs Yes | 0.085 | 0.703 | 0.470 | 1.050 |
Liver metastasis | Yes vs No | <0.001 | 1.645 | 1.263 | 2.142 |
Lymph node metastasis | Yes vs No | 0.023 | 1.250 | 1.031 | 1.516 |
Second line treatment | No vs Yes | <0.001 | 1.398 | 1.184 | 1.651 |